Assessment effect of suppository of a drug based on Percian medicine on bacterial vaginosis
- Conditions
- bacterial vaginosis.Acute vaginitisinitis
- Registration Number
- IRCT2016062528613N1
- Lead Sponsor
- Tehran University of Medical Science
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete
- Sex
- Female
- Target Recruitment
- 120
Outpatient women aged 18- 50 years with symptoms such as burning and itching refer and amsel criteria for bacterial vaginosis is positive for them; that Both treatments (chemical or herbal) do not use;They do not suffer from organic diseases such as cancer or other malignancies of the uterus or ovaries or Patients with chronic diseases. Exclusion criteria: Patients who use other antibiotics during the study; Patients who are experiencing possible side effect; Patients who have other medical interventions needed;This group of patients who have a severe form of the disease and other therapies and may require hospitalization have been included; Patients who request personal decision to withdraw from the study; Patients with immunosuppressive disorders; people with HIV; Patients with other infections such as genital herpes or trichomoniasis or fungal or gonorrhea at the same time with bacterial vaginosis; People who take other medication Such as the use of immunosuppressive drug or consumers of anti-inflammatory;consumers of showers vaginal and vaginal acidifying agents
Not provided
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Amsel criteria. Timepoint: Before the intervention,10-14 days after begining of treatment. Method of measurement: Amsel have 4 criteria: key cells in the wet mount vaginal sample Vaginal dyscharge thin and white uniform - gray, white or yellowish, Vaginal pH equal to or greater than 4/5, positive whiff test. If at least 3 of the 4 cases mentioned above is positive, bacterial vaginosis is brought on .;Clinical signs for example Malodorous discharge, Itching, dyspareunia, having bad smell during sexual intercourse. Timepoint: Before the intervention, 10-14 day after intervention. Method of measurement: Measured by asking from patient.
- Secondary Outcome Measures
Name Time Method Side effects. Timepoint: Within 10 to 14 days of intervention. Method of measurement: questionnaire.